Stratos Wealth Partners, Ltd. Novo Nordisk A S Transaction History

Stratos Wealth Partners, Ltd.

$6.9 Billion
Q4 2024

A detailed history of Stratos Wealth Partners, Ltd. transactions in Novo Nordisk A S stock. As of the latest transaction made, Stratos Wealth Partners, Ltd. holds 25,361 shares of NVO stock, worth $1.57 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

25,361

Previous 28,540 11.14%

Holding current value

$1.57 Million

Previous $3.4 Million 35.82%

% of portfolio

0.03%

Previous 0.05%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	SELL	$85.0 - $120.04 $270,215 - $381,607	-3,179 Reduced 11.14%	25,361 $2.18 Million
Q3 2024 Oct 17, 2024	BUY	$119.07 - $145.42 $89,659 - $109,501	753 Added 2.71%	28,540 $3.4 Million
Q2 2024 Jul 24, 2024	BUY	$122.71 - $146.91 $371,934 - $445,284	3,031 Added 12.24%	27,787 $3.97 Million
Q1 2024 Apr 16, 2024	BUY	$102.11 - $135.92 $353,300 - $470,283	3,460 Added 16.25%	24,756 $3.18 Million
Q4 2023 Jan 24, 2024	BUY	$87.78 - $105.45 $301,875 - $362,642	3,439 Added 19.26%	21,296 $2.2 Million
Q3 2023 Oct 24, 2023	BUY	$90.94 - $199.54 $1.13 Million - $2.48 Million	12,427 Added 228.86%	17,857 $1.62 Million
Q2 2023 Jul 18, 2023	BUY	$155.98 - $172.65 $210,261 - $232,732	1,348 Added 33.02%	5,430 $878,000
Q1 2023 Apr 27, 2023	SELL	$132.34 - $159.14 $111,297 - $133,836	-841 Reduced 17.08%	4,082 $649,000
Q4 2022 Jan 19, 2023	BUY	$102.55 - $135.33 $74,246 - $97,978	724 Added 17.24%	4,923 $0
Q3 2022 Oct 24, 2022	BUY	$95.28 - $116.93 $12,386 - $15,200	130 Added 3.19%	4,199 $418,000
Q2 2022 Jul 22, 2022	BUY	$103.24 - $121.81 $134,728 - $158,962	1,305 Added 47.21%	4,069 $453,000
Q1 2022 Apr 26, 2022	BUY	$93.1 - $112.54 $59,397 - $71,800	638 Added 30.01%	2,764 $307,000
Q4 2021 Jan 14, 2022	BUY	$95.88 - $117.08 $203,840 - $248,912	2,126 New	2,126 $238,000
Q4 2018 Feb 08, 2019	SELL	$41.54 - $47.25 $32,151 - $36,571	-774 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$46.76 - $51.24 $36,192 - $39,659	774 New	774 $36,000
Q2 2018 Aug 13, 2018	SELL	$44.29 - $50.42 $65,549 - $74,621	-1,480 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$48.49 - $58.14 $33,167 - $39,767	684 Added 85.93%	1,480 $73,000
Q4 2017 Feb 09, 2018	BUY	$47.53 - $53.73 $37,833 - $42,769	796	796 $43,000

Others Institutions Holding NVO

# of Institutions

1,861

Shares Held

337M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $140B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.

Account

Stratos Wealth Partners, Ltd. Novo Nordisk A S Transaction History